PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
INSP vs. BMY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


INSPBMY
YTD Return-0.68%20.84%
1Y Return60.73%23.64%
3Y Return (Ann)-10.26%3.68%
5Y Return (Ann)26.30%3.79%
Sharpe Ratio0.860.79
Sortino Ratio1.451.43
Omega Ratio1.241.18
Calmar Ratio0.960.47
Martin Ratio2.481.95
Ulcer Index23.84%11.53%
Daily Std Dev69.05%28.40%
Max Drawdown-61.59%-70.62%
Current Drawdown-38.04%-20.85%

Fundamentals


INSPBMY
Market Cap$6.05B$121.33B
EPS$1.10-$3.58
Total Revenue (TTM)$755.59M$47.44B
Gross Profit (TTM)$640.54M$33.40B
EBITDA (TTM)$22.48M$18.32B

Correlation

-0.50.00.51.00.2

The correlation between INSP and BMY is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

INSP vs. BMY - Performance Comparison

In the year-to-date period, INSP achieves a -0.68% return, which is significantly lower than BMY's 20.84% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
27.40%
35.51%
INSP
BMY

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INSP vs. BMY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INSP
Sharpe ratio
The chart of Sharpe ratio for INSP, currently valued at 0.88, compared to the broader market-4.00-2.000.002.004.000.88
Sortino ratio
The chart of Sortino ratio for INSP, currently valued at 1.47, compared to the broader market-4.00-2.000.002.004.006.001.47
Omega ratio
The chart of Omega ratio for INSP, currently valued at 1.24, compared to the broader market0.501.001.502.001.24
Calmar ratio
The chart of Calmar ratio for INSP, currently valued at 0.99, compared to the broader market0.002.004.006.000.99
Martin ratio
The chart of Martin ratio for INSP, currently valued at 2.54, compared to the broader market0.0010.0020.0030.002.54
BMY
Sharpe ratio
The chart of Sharpe ratio for BMY, currently valued at 0.79, compared to the broader market-4.00-2.000.002.004.000.79
Sortino ratio
The chart of Sortino ratio for BMY, currently valued at 1.43, compared to the broader market-4.00-2.000.002.004.006.001.43
Omega ratio
The chart of Omega ratio for BMY, currently valued at 1.18, compared to the broader market0.501.001.502.001.18
Calmar ratio
The chart of Calmar ratio for BMY, currently valued at 0.47, compared to the broader market0.002.004.006.000.47
Martin ratio
The chart of Martin ratio for BMY, currently valued at 1.95, compared to the broader market0.0010.0020.0030.001.95

INSP vs. BMY - Sharpe Ratio Comparison

The current INSP Sharpe Ratio is 0.86, which is comparable to the BMY Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of INSP and BMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
0.88
0.79
INSP
BMY

Dividends

INSP vs. BMY - Dividend Comparison

INSP has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.07%.


TTM20232022202120202019201820172016201520142013
INSP
Inspire Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BMY
Bristol-Myers Squibb Company
4.07%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%3.31%

Drawdowns

INSP vs. BMY - Drawdown Comparison

The maximum INSP drawdown since its inception was -61.59%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for INSP and BMY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-38.04%
-20.85%
INSP
BMY

Volatility

INSP vs. BMY - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) and Bristol-Myers Squibb Company (BMY) have volatilities of 12.91% and 12.84%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
12.91%
12.84%
INSP
BMY

Financials

INSP vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items